Financhill
Back

GeneDx Holdings Quote, Financials, Valuation and Earnings

GeneDx Holdings Price Quote

$37.81
-0.06 (-0.92%)
(Updated: September 14, 2024 at 6:52 AM ET)

GeneDx Holdings Key Stats

Sell
39
GeneDx Holdings (WGS) is a Sell

Day range:
$36.96 - $38.95
52-week range:
$1.16 - $38.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.06
P/B ratio:
5.26%

Volume:
339.5K
Avg. volume:
368.4K
1-year change:
702.33%
Market cap:
$1B
Revenue:
$202.6M
EPS:
$-4.44

How Much Does GeneDx Holdings Make?

Is GeneDx Holdings Growing As A Company?

  • What Is GeneDx Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.45%
  • What Is GeneDx Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

GeneDx Holdings Stock Price Performance

  • Did GeneDx Holdings Stock Go Up Last Month?
    GeneDx Holdings share price went up by 10.89% last month
  • Did WGS's Share Price Rise Over The Last Year?
    WGS share price rose by 702.33% over the past 1 year

What Is GeneDx Holdings 52-Week High & Low?

GeneDx Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GeneDx Holdings?

  • How Much Debt Does GeneDx Holdings Have?
    Total long term debt quarterly is $52.2M
  • How Much Cash Does GeneDx Holdings Have?
    Cash and short term investments quarterly total is $106.9M
  • What Is GeneDx Holdings’s Book Value Per Share?
    Book value per share is 7.21

Is GeneDx Holdings Cash Flow Positive?

  • What Is WGS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$92M
  • What Is GeneDx Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $45.4M
  • What Is GeneDx Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$53.9M

GeneDx Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    WGS return on invested capital is -43.52%
  • What Is GeneDx Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -28.02%
  • What Is WGS Return On Equity?
    ROE is a measure of profitability and is -49.79%

GeneDx Holdings Earnings Date & Stock Price

GeneDx Holdings Competitors

  • Who Are GeneDx Holdings's Competitors?
    Below is a list of companies who compete with GeneDx Holdings or are related in some way:
    • DarioHealth Corp (DRIO)
    • FOXO Technologies Inc (FOXO)
    • National Research Corp (NRC)
    • Ontrak Inc (OTRK)
    • Spok Holdings Inc (SPOK)

GeneDx Holdings Dividend Yield

GeneDx Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 65.7%
Revenue: 44.78% 18.89%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 40.83
Upside from Last Price: 7.83%

Major Shareholders

  • How many WGS shares are owned by institutional investors?
    19M WGS shares are owned by institutional investors
  • How many WGS shares are owned by insiders?
    1.2M WGS shares are owned by insiders